Abbott LaboratoriesABT -0.04%80 OCF Margin % is 11.78% as of Mar. 2026, which is 43% below its 10-year median of 20.50. GuruFocus rates ABT with a GF Score™ of 80/100 and a GF Value™ of $129.49 (Significantly Undervalued). Among 815 Medical Devices & Instruments companies, Abbott Laboratories ranks better than 81.35% on this metric.
The historical rank and industry rank for Abbott Laboratories's OCF Margin % or its related term are showing as below:
ABT'
s OCF Margin % Range Over the Past 10 Years
Min: 15.36 Med: 20.5 Max: 24.45
Current: 20.97
During the past 13 years, the highest OCF Margin % of Abbott Laboratories was 24.45%. The lowest was 15.36%. And the median was 20.50%.
ABT's OCF Margin % is ranked better than 81.35% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: 5.86
vs ABT: 20.97
Abbott Laboratories OCF Margin % Related Terms
Abbott Laboratories OCF Margin % Historical Data
* Premium members only.
The historical data trend for Abbott Laboratories's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Abbott Laboratories's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Abbott Laboratories OCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Abbott Laboratories's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Abbott Laboratories's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Abbott Laboratories (ABT) has a OCF Margin % of 11.78% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Abbott Laboratories and its competitors. This is 43% below median its historical median of 20.50. Over the past decade, Abbott Laboratories' OCF Margin % has ranged from 15.36 to 24.45. According to the industry distribution chart, Abbott Laboratories ranks #152 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 18.7%.
Is Abbott Laboratories' OCF Margin % too high?
Abbott Laboratories' current OCF Margin % of 11.78% is 43% below median its 10-year median of 20.50. Over the past 10 years, this metric has ranged from a low of 15.36 to a high of 24.45. The Medical Devices & Instruments industry median OCF Margin % is 5.86. Abbott Laboratories' value of 11.78% is 101% above this industry median. Based on the distribution chart, Abbott Laboratories ranks #152 out of 815 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Abbott Laboratories has a GF Score™ of 80/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Abbott Laboratories' OCF Margin % compare to SYK and MDT?
According to the Medical Devices & Instruments industry distribution chart, Abbott Laboratories ranks #152 out of 815 companies for OCF Margin %. This places Abbott Laboratories in the top 19% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 5.86. Abbott Laboratories' value of 11.78% is 101% above this benchmark. Historically, Abbott Laboratories' own OCF Margin % has ranged from 15.36 to 24.45 over the past decade. While the company's 10-year median is 20.50 vs. the industry median of 5.86, Abbott Laboratories has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.86, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Abbott Laboratories's current OCF Margin % of 11.78% is 101% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Abbott Laboratories and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Abbott Laboratories's current OCF Margin % is 11.78%, which is 43% below median its own 10-year median of 20.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abbott Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Abbott Laboratories (ABT) is currently considered Significantly Undervalued. The stock's GF Value™ is $129.49, compared to a current price of $90.49 — trading 30.1% below its estimated fair value. The current OCF Margin % is 11.78%, which is 43% below median its 10-year median of 20.50 and 101% above the Medical Devices & Instruments industry median of 5.86. Abbott Laboratories' overall GF Score™ is 80/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Abbott Laboratories (ABT), the current OCF Margin % is 11.78% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Abbott Laboratories (ABT) Overvalued in 2026?
Based on GuruFocus' analysis, Abbott Laboratories stock appears to be undervalued.
The current stock price of $90.49 is trading 30.1% below its estimated GF Value™ of $129.49.
GuruFocus considers Abbott Laboratories to be Significantly Undervalued.
Key valuation signals for ABT:
OCF Margin %: 11.78% (43% below median its 10-year median of 20.50)
GF Value™: $129.49 vs. price of $90.49 (30.1% below fair value)
Industry Position: 101% above the Medical Devices & Instruments median (#152 of 815)
No single metric tells the full story. See the ABT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
80GF Score
Get the complete analysis for ABT
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ABT has been successfully added to your 
